Trypanosomatid diseases molecular routes to drug discovery /
Furkejuvvon:
| Searvvušdahkki: | |
|---|---|
| Eará dahkkit: | , , |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Weinheim :
Wiley-VCH,
2013.
|
| Ráidu: | Drug discovery in infectious diseases ;
v. 4. |
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- pt. 1. Disease burden, current treatments, medical needs, and strategic approaches
- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery
- pt. 3. Validation and selection of drug targets in kinetoplasts
- pt. 4. Examples of target-based approaches and compounds under consideration.